Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Support MFO
Donate through PayPal
The Bespoke EFT Matrix Report: Small-Caps, Biotech Struggle As Election Nears
FYI: US equity markets finished the week solidly in the red, led lower by small-caps and biotechs. The Russell 2,000 small-cap ETF (IWM) fell 1.95% on the week, putting it down 3% for the quarter already. Even still, IWM is up 6.93% year-to-date, which is more than 200 basis points better than the S&P 500’s (SPY) change.
You can view the recent performance of all asset classes in our key ETF matrix below.
